BMN 331 is an experimental gene therapy for hereditary angioedema, delivered by adeno-associated virus type 5 and targeting the SERPING1 gene.
References
Wikipedia
BMN 331
Tags
- Experimental gene therapies
- Genetics stubs
AffiliateWikipedia
BMN 331 is an experimental gene therapy for hereditary angioedema, delivered by adeno-associated virus type 5 and targeting the SERPING1 gene.
References